History of the Lympha Press®

In the 1970's, Professor Avigdor Zelikovski, Chief of Vascular Surgery at Beilinson Hospital in central Israel, was experimenting with intermittent compression devices for treatment of lymphedema. His clinic was filled with patients from the former Soviet Union, all with untreated severe lymphedema, neglected for years. Many of these patients had chronic infections and considerable fibrosis. Dissatisfied by the intermittent pumps currently available, and frustrated by their inability to alleviate his patients' suffering, he proposed a new sequential compression device for treatment of lymphedema. Unique to his device: numerous, narrow cells arrayed in overlapping fashion, so that when sequentially filled with air, they applied a gentle "milking" effect to the patient's limb. This "milking effect" effectively assisted the movement of accumulated lymphatic fluid from the swollen limb to the healthy lymphatics in the patient's torso. Early clinical tests of the new device showed remarkable results, and Professor Zelikovski brought the device to Mego Afek for further development.

Mego Afek developed and perfected Professor Zelikovski's original model, and the resulting device, called Lympha Press®, totally revolutionized lymphedema treatment. The Lympha Press® was tested extensively in major teaching hospitals and clinics in the USA as well as internationally, with published medical research showing the effectiveness and safety of Lympha Press® lymphedema treatment.

The years following have seen increased competition; nevertheless the superiority of our original patented design and continual improvements, as well as our insistence on quality, safety and efficacy, have maintained Lympha Press®'s international standing as the number one physician recommended compression therapy system for treatment of lymphedema and venous disorders.